secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioStem Technologies, Inc. (BSEM)
CIK:        0001658678
Form:       8-K
Filed at:   2026-09-18T20:15:16+00:00
Accession:  0001193125-26-395556
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioStem secures up to $40M committed equity facility with Roth Principal Investments
--------------------------------------------------------------------------------

- Facility allows BioStem to sell up to $40M shares at its discretion over a 36-month term.
- Market Open/Intraday purchases priced at 3% VWAP discount; Pre/Post-Market at 5% discount.
- Pays $400k cash commitment fee (1% of facility) plus $75k legal and $50k QIU fees.
- Exchange cap of 19.99% (3,585,375 shares) unless avg price >=$4.3056 or shareholder approval.
- Proceeds intended for working capital and general corporate purposes; no obligation to draw.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658678/000119312526395556/0001193125-26-395556-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658678/000119312526395556/bsem-20260918.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-395556

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer